furosemide has been researched along with kanamycin a in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (32.05) | 18.7374 |
1990's | 4 (5.13) | 18.2507 |
2000's | 9 (11.54) | 29.6817 |
2010's | 34 (43.59) | 24.3611 |
2020's | 6 (7.69) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Iaroshevich, VI | 1 |
Hybels, RL | 1 |
Laitakari, K | 1 |
Ohtani, I; Ohtsuki, K; Omata, T; Ouchi, J; Saito, T | 2 |
Asakuma, S; Lowry, LD; Snow, JB | 1 |
Nakai, Y | 1 |
Aranda, JV; Cohen, S; Neims, AH | 1 |
Dunn, E; Kirsh, MM; Lee, R; Nishiyama, R; Prager, R; Sloan, H; Straker, J | 1 |
Pedersen, CB; Sorensen, H | 1 |
Ono, T; Tachibana, M | 1 |
Konishi, K; Nakai, Y; Yamane, H | 1 |
Allen, LV; Desai, SR; Rao, PS; Thompson, DF | 1 |
Rybak, LP | 1 |
Bigos, T; Crossley, K; Joffe, CD | 1 |
Bewick, M; Brown, CB; Cameron, JS; Ogg, CS | 1 |
Falk, SA | 1 |
Gavras, H; Hartz, S; Lawson, DH; Linton, AL; Macadam, RF; Singh, MH; Turnbull, D | 1 |
D'Arcy, PF; Harpur, ES | 1 |
Humes, LE | 1 |
Minowa, Y | 1 |
Bleeker, JD; Wit, HP | 1 |
Hata, T; Sakamoto, K; Suzuki, H; Takeda, U; Yokota, M | 1 |
Lietman, PS; Smith, CR | 1 |
Komune, S; Snow, JB | 1 |
Mirahmadi, MK; Vaziri, ND | 1 |
Garraghty, PE; Kaas, JH; Schwaber, MK | 1 |
Butterfield, DA; Clerici, WJ; DiMartino, DL; Hensley, K | 1 |
Alam, SA; Ikeda, K; Katori, Y; Kawase, T; Kikuchi, T; Takasaka, T; Watanabe, K | 1 |
Clark, G; Hardman, J; O'leary, S; Richardson, R; Wise, AK | 1 |
Agterberg, MJ; de Groot, JC; Klis, SF; Smoorenburg, GF; Versnel, H | 1 |
Campbell, S; Forge, A; Hume, CR; Oesterle, EC; Taylor, RR | 1 |
Agterberg, MJ; Albers, FW; de Groot, JC; Klis, SF; Smoorenburg, GF; Versnel, H | 1 |
Agterberg, MJ; de Groot, JC; Klis, SF; van Dijk, LM; Versnel, H | 1 |
Basak, O; Bermingham-McDonogh, O; Hartman, BH; Nelson, BR; Reh, TA; Taylor, V | 1 |
Campbell, S; Oesterle, EC | 1 |
Camarero, G; García-Alcántara, F; Murillo-Cuesta, S; Rivera, T; Sistiaga, JA; Vacas, E; Varela-Nieto, I | 1 |
Chen, J; Chen, QG; Chu, HQ; Cui, YH; Huang, XW; Li, JL; Li, ZY; Wang, Y; Xiong, H; Zhou, LQ | 1 |
Agterberg, MJ; de Groot, JC; Grolman, W; Havenith, S; Klis, SF; Sedee, RJ; Versnel, H | 1 |
Grolman, W; Klis, SF; Prijs, VF; Stronks, HC; Versnel, H | 1 |
Hirose, K; Sato, E | 1 |
Chen, J; Chen, Q; Chu, H; Cui, Y; Huang, X; Li, J; Li, Z; Wang, Y; Xiong, H; Zhou, L; Zhou, X | 1 |
Chen, X; Huang, G; Jiang, H | 1 |
Bremer, HG; de Groot, JC; Klis, SF; Versnel, H | 1 |
Chimona, TS; Grolman, W; Klis, SF; Prijs, VF; Stronks, HC | 1 |
Agterberg, MJ; de Groot, JC; Grolman, W; Klis, SF; Ramekers, D; van Loon, MC; Versnel, H | 1 |
Grolman, W; Hendriksen, FG; Klis, SF; Ramekers, D; Van Deurzen, MH; Waaijer, L | 1 |
Brough, DE; Hsu, C; Kraft, S; Staecker, H | 1 |
Bremer, HG; Grolman, W; Hendriksen, FG; Jansen, TT; Klis, SF; Topsakal, V | 1 |
Grolman, W; Havenith, S; Klis, SF; Versnel, H | 2 |
Gao, J; Guo, WW; Han, DY; Li, Z; Sun, AL; Sun, DX; Sun, JH; Wei, XN; Yang, SM; Zhang, XF | 1 |
Johnson, SB; Santi, PA; Schmitz, HM | 1 |
Fernandes, VT; Lin, VY | 1 |
Hirose, K; Li, SZ; Ohlemiller, KK; Ransohoff, RM | 1 |
Grolman, W; Klis, SF; Ramekers, D; Strahl, SB; Versnel, H | 1 |
Hu, H; Nie, C; Shen, C; Wu, H; Xiang, M; Ye, B | 1 |
Chen, Y; Qiao, L; Qiu, J; Wang, Y; Wen, L; Wu, S; Yue, B | 1 |
Bezdjian, A; Grolman, W; Hendriksen, FG; Klis, SF; van der Linden, CA; Żak, M | 1 |
Kaur, T; Ohlemiller, KK; Warchol, ME | 1 |
Bermúdez-Muñoz, JM; García-Alcántara, F; Martínez-Vega, R; Milo, M; Murillo-Cuesta, S; Pulido, S; Rivera, T; Varela-Nieto, I | 1 |
Qiu, J; Qiu, Y; Song, Y; Sun, F; Tian, K; Wang, R; Yue, B; Zha, D; Zhou, K | 1 |
Deng, X; Hu, Z; Li, X; Liu, Z; Zhou, Y | 1 |
Chen, F; Chen, J; Li, W; Liu, Z; Mi, W; Qiu, J; Wang, R; Xing, W; Yan, H; Zha, D | 1 |
Klis, SFL; Ramekers, D; Versnel, H | 1 |
Deng, X; Hu, Z | 1 |
Fan, C; Hu, H; Shen, Y; Wang, Q; Xiang, M; Ye, B; Zou, T | 1 |
Bako, P; Gerlinger, I; Löwenheim, H; Müller, M; Wolpert, S | 1 |
Ahrens, D; Bankstahl, JP; Behrends, W; Esser, KH; Lenarz, T; Paasche, G; Scheper, V | 1 |
Li, C; Yang, C; Yang, J; Yi, J | 1 |
1 review(s) available for furosemide and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for furosemide and kanamycin a
Article | Year |
---|---|
High dose frusemide in acute reversible intrinsic renal failure. A preliminary communication.
Topics: Acute Kidney Injury; Adult; Clinical Trials as Topic; Deafness; Furosemide; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Oliguria; Peritoneal Dialysis; Renal Dialysis | 1974 |
Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Interactions; Ear; Ethacrynic Acid; Furosemide; Humans; Kanamycin; Kidney; Middle Aged | 1983 |
75 other study(ies) available for furosemide and kanamycin a
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Ototoxicity of some drug agents].
Topics: Age Factors; Aminoglycosides; Bleomycin; Cochlea; Deafness; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Ear; Ethacrynic Acid; Furosemide; Hearing Disorders; Humans; Kanamycin; Neomycin; Streptomycin; Toxicology; Vestibule, Labyrinth; Viomycin | 1975 |
Drug toxicity of the inner ear.
Topics: Animals; Chloroquine; Dihydrostreptomycin Sulfate; Ethacrynic Acid; Furosemide; Gentamicins; Humans; Kanamycin; Labyrinth Diseases; Neomycin; Quinine; Salicylates; Streptomycin; Tobramycin | 1979 |
Vestibular disorders in medically managed chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Audiometry; Caloric Tests; Deafness; Ear; Electronystagmography; Female; Furosemide; Hearing Disorders; Humans; Kanamycin; Kidney Failure, Chronic; Labyrinth Diseases; Male; Middle Aged; Streptomycin; Vestibular Function Tests; Vestibule, Labyrinth | 1977 |
Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics.
Topics: Aminoglycosides; Animals; Body Fluids; Body Weight; Cochlea; Drug Synergism; Furosemide; Gentamicins; Kanamycin; Kidney; Rabbits; Streptomycin | 1978 |
Endocochlear DC potential in kanamycin-sulfate-treated guinea pigs.
Topics: Action Potentials; Animals; Cochlea; Furosemide; Guinea Pigs; Hypoxia; Kanamycin | 1977 |
[Interaction of bumetanide and kanamycin (author's transl)].
Topics: Animals; Bumetanide; Diuretics; Drug Interactions; Ear Diseases; Ear, Middle; Furosemide; Hair Cells, Auditory; Kanamycin; Kidney Tubules, Proximal; Rabbits | 1978 |
Combined effect of 3', 4'-dideoxykanamycin B and potent diuretics on the cochlea. (A scanning and transmission electron microscopic evaluation).
Topics: Animals; Cochlea; Dibekacin; Drug Synergism; Ethacrynic Acid; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing Disorders; Kanamycin; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Mitochondria; Organ of Corti | 1977 |
Drug utilization in a newborn intensive care unit.
Topics: Ampicillin; Bicarbonates; Birth Weight; Canada; Chloramphenicol; Drug Therapy, Combination; Drug Utilization; Female; Furosemide; Gentamicins; Gestational Age; Gluconates; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units; Kanamycin; Male; Penicillin G | 1976 |
The benefits of corticosteroids in endotoxic shock.
Topics: Animals; Assisted Circulation; Cardiac Output; Cardiopulmonary Bypass; Dogs; Escherichia coli; Furosemide; Glucocorticoids; Hemodynamics; Hypothermia, Induced; Kanamycin; Lung; Mesenteric Vascular Occlusion; Methylprednisolone; Myocardium; Shock, Septic; Time Factors; Water-Electrolyte Balance | 1975 |
[Scanning electron microscopy of the inner ear as a screening test for ototoxicity].
Topics: Animals; Cochlea; Ear, Inner; Furosemide; Guinea Pigs; Kanamycin; Mass Screening; Microscopy, Electron, Scanning | 1975 |
Origin of the endolymphatic DC potential in the cochlea and ampulla of the guinea pig.
Topics: Action Potentials; Animals; Cell Hypoxia; Cochlea; Endolymph; Furosemide; Guinea Pigs; Kanamycin; Semicircular Canals; Streptomycin | 1990 |
Furosemide-induced alteration of drug pathway to cochlea.
Topics: Animals; Cochlea; Drug Synergism; Fluorescent Antibody Technique; Furosemide; Guinea Pigs; Kanamycin; Organ of Corti; Time Factors | 1988 |
Compatibility of furosemide with aminoglycoside admixtures.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Drug Combinations; Drug Incompatibility; Furosemide; Gentamicins; Hydrogen-Ion Concentration; Kanamycin; Netilmicin; Tobramycin | 1985 |
Furosemide ototoxicity: clinical and experimental aspects.
Topics: Animals; Cats; Chinchilla; Cochlea; Cochlear Duct; Cochlear Microphonic Potentials; Dose-Response Relationship, Drug; Drug Synergism; Endolymph; Female; Furosemide; Guinea Pigs; Hair Cells, Auditory; Humans; Kanamycin; Male; Potassium; Rats; Vestibulocochlear Nerve | 1985 |
Hemophilus influenzae pericarditis. A report of two cases in adults with a summary of the literature.
Topics: Adult; Ampicillin; Child; Child, Preschool; Chloramphenicol; Female; Furosemide; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Kanamycin; Male; Pericarditis; Streptomycin | 1973 |
Combined effects of noise and ototoxic drugs.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Diuretics; Environmental Exposure; Ethacrynic Acid; Furosemide; Guinea Pigs; Haplorhini; Hearing Disorders; Humans; Kanamycin; Microscopy, Electron; Neomycin; Noise; Occupational Diseases; Organ of Corti; Quinine; Salicylates; Sound; Streptomycin | 1972 |
Effect of furosemide on antibiotic-induced renal damage in rats.
Topics: Animals; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Colistin; Female; Furosemide; Glycerol; Kanamycin; Kidney; Kidney Tubules, Proximal; Necrosis; Organ Size; Rats; Time Factors; Urea | 1972 |
Laboratory testing for ototoxic effects of drugs.
Topics: Animals; Ear Diseases; Ethacrynic Acid; Furosemide; Hearing Disorders; Hearing Tests; Kanamycin; Mice; Mice, Inbred Strains; Reflex, Startle; Toxicology | 1973 |
Noise-induced hearing loss as influenced by other agents and by some physical characteristics of the individual.
Topics: Acoustic Stimulation; Age Factors; Animals; Ethacrynic Acid; Eye Color; Furosemide; Hearing Loss, Noise-Induced; Hearing Loss, Sensorineural; Humans; Kanamycin; Melanins; Neomycin; Presbycusis; Risk; Salicylates; Vibration | 1984 |
[Sensorineural hearing impairment by combined administration of aminoglycoside drugs, loop diuretics and an anticancer drug (cisplatin)--an experimental study].
Topics: Animals; Cisplatin; Drug Therapy, Combination; Furosemide; Guinea Pigs; Hearing Loss, Sensorineural; Kanamycin; Organ of Corti | 1984 |
A possible method to study transient effects of ototoxic agents on the vestibular system.
Topics: Animals; Cochlear Nerve; Columbidae; Ethacrynic Acid; Evoked Potentials, Auditory; Furosemide; Kanamycin; Vestibular Nerve; Vestibule, Labyrinth | 1983 |
[Ocular and auditory organs of Ochotona rufescens].
Topics: Animals; Animals, Laboratory; Atropine; Dogs; Ear, Inner; Electroretinography; Furosemide; Guinea Pigs; Kanamycin; Lagomorpha; Mammals; Pilocarpine; Pupil; Rats; Rats, Inbred Strains; Reflex, Acoustic; Retina | 1983 |
Nature of the endocochlear dc potential in kanamycin-poisoned guinea pigs.
Topics: Animals; Cochlea; Cochlear Duct; Evoked Potentials, Auditory; Furosemide; Guinea Pigs; Infusions, Parenteral; Kanamycin; Perfusion; Scala Tympani; Stria Vascularis | 1982 |
Hearing loss in end-stage renal disease - effect of dialysis.
Topics: Furosemide; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Renal Dialysis; Vancomycin | 1980 |
Neuroplasticity of the adult primate auditory cortex following cochlear hearing loss.
Topics: Animals; Audiometry, Pure-Tone; Auditory Cortex; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Hearing Loss, Sensorineural; Kanamycin; Macaca mulatta | 1993 |
Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Cochlea; Cyclic N-Oxides; Diuretics; Electron Spin Resonance Spectroscopy; Ethacrynic Acid; Female; Furosemide; Gentamicins; Guinea Pigs; Hydrogen Peroxide; Hydroxyl Radical; Kanamycin; Male; Perilymph; Quinine; Spin Labels; Trimethyltin Compounds | 1996 |
Acute effects of combined administration of kanamycin and furosemide on the stria vascularis studied by distortion product otoacoustic emission and transmission electron microscopy.
Topics: Animals; Anti-Bacterial Agents; Diuretics; Drug Synergism; Furosemide; Guinea Pigs; Hearing Loss; Kanamycin; Microscopy, Electron; Otoacoustic Emissions, Spontaneous; Stria Vascularis | 1998 |
Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Count; Cell Survival; Cochlea; Cochlear Implantation; Deafness; Disease Models, Animal; Furosemide; GAP-43 Protein; Guinea Pigs; Immunohistochemistry; Kanamycin; Models, Biological; Nerve Degeneration; Nerve Regeneration; Neurofilament Proteins; Neurons, Afferent; Neurotrophin 3; Time Factors | 2005 |
Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
Topics: Action Potentials; Animals; Anti-Bacterial Agents; Cell Survival; Cochlea; Deafness; Electrophysiology; Female; Furosemide; Ganglia; Ganglia, Spinal; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Sodium Potassium Chloride Symporter Inhibitors | 2007 |
Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Biomarkers; Calcium-Binding Proteins; Chickens; Cochlear Diseases; Disease Models, Animal; Diuretics; Furosemide; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kanamycin; Membrane Proteins; Mice; Mice, Inbred CBA; Organ of Corti; Serrate-Jagged Proteins; SOXB1 Transcription Factors; Time Factors | 2008 |
Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cochlea; Electrons; Female; Furosemide; Guinea Pigs; Kanamycin; Microscopy, Electron; Mitochondria; Myelin Sheath; Neurons; Spiral Ganglion | 2008 |
Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Survival; Cochlear Implants; Deafness; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Guinea Pigs; Kanamycin; Models, Animal; Nerve Degeneration; Protein Synthesis Inhibitors; Sodium Potassium Chloride Symporter Inhibitors; Spiral Ganglion | 2009 |
Hes5 expression in the postnatal and adult mouse inner ear and the drug-damaged cochlea.
Topics: Aging; Animals; Basic Helix-Loop-Helix Transcription Factors; Cochlea; Ear, Inner; Epithelium; Furosemide; Green Fluorescent Proteins; Kanamycin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Animal; Protein Synthesis Inhibitors; Receptors, Notch; Regeneration; Repressor Proteins; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors | 2009 |
Supporting cell characteristics in long-deafened aged mouse ears.
Topics: Aging; Animals; Biomarkers; Calcium-Binding Proteins; Cell Differentiation; Deafness; Diuretics; Furosemide; Hair Cells, Auditory; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kanamycin; Labyrinth Supporting Cells; Membrane Proteins; Mice; Protein Synthesis Inhibitors; Serrate-Jagged Proteins; SOXB1 Transcription Factors; Spiral Ganglion; Tubulin | 2009 |
Direct drug application to the round window: a comparative study of ototoxicity in rats.
Topics: Administration, Topical; Animals; Cochlea; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hearing Loss; Injections, Intravenous; Injections, Subcutaneous; Kanamycin; Male; Random Allocation; Rats; Rats, Wistar; Round Window, Ear | 2009 |
[Rapid cochlea lesion induced by co-administration of kanamycin and furosemide in mouse].
Topics: Animals; Cell Death; Cochlea; Disease Models, Animal; Drug Synergism; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory; Kanamycin; Mice; Mice, Inbred CBA | 2010 |
Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival; Disease Models, Animal; Drug Carriers; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Gelatin Sponge, Absorbable; Guinea Pigs; Hearing Loss; Kanamycin; Neuroprotective Agents; Spiral Ganglion; Time Factors | 2011 |
Effects of electrical stimulation on the acoustically evoked auditory-nerve response in guinea pigs with a high-frequency hearing loss.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Cochlea; Cochlear Implantation; Cochlear Microphonic Potentials; Cochlear Nerve; Disease Models, Animal; Female; Furosemide; Guinea Pigs; Hearing Loss, High-Frequency; Kanamycin; Time Factors | 2011 |
Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.
Topics: Acoustic Stimulation; Animals; Atrophy; Auditory Threshold; Cell Death; Cell Movement; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes | 2011 |
Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Auditory Threshold; Cell Death; Cell Survival; Cochlea; Cochlear Microphonic Potentials; Disease Models, Animal; Diuretics; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred CBA; Protein Synthesis Inhibitors; Stria Vascularis; Time Factors | 2011 |
Effects of NasoPore packing in the middle ear cavity of the guinea pig.
Topics: Animals; Anti-Bacterial Agents; Auditory Threshold; Cell Count; Diuretics; Ear, Inner; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Foreign-Body Reaction; Furosemide; Gelatin Sponge, Absorbable; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Microscopy, Electron, Scanning; Polyurethanes; Tampons, Surgical | 2011 |
Combined administration of kanamycin and furosemide does not result in loss of vestibular function in Guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Diuretics; Female; Furosemide; Gentamicins; Guinea Pigs; Hair Cells, Vestibular; Kanamycin; Otolithic Membrane; Vestibular Evoked Myogenic Potentials; Vestibular Function Tests | 2012 |
Spatial overlap of combined electroacoustic stimulation determines the electrically evoked response in the guinea pig cochlea.
Topics: Acoustic Impedance Tests; Acoustic Stimulation; Action Potentials; Animals; Anti-Bacterial Agents; Cochlea; Data Interpretation, Statistical; Diuretics; Electric Stimulation; Evoked Potentials, Auditory; Female; Furosemide; Guinea Pigs; Hearing Loss, High-Frequency; Kanamycin; Noise | 2012 |
Spiral ganglion cell morphology in guinea pigs after deafening and neurotrophic treatment.
Topics: Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival; Deafness; Disease Models, Animal; Female; Furosemide; Ganglia, Spinal; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Nerve Degeneration; Neurons; Time Factors | 2013 |
The peripheral processes of spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs.
Topics: Animals; Brain-Derived Neurotrophic Factor; Deafness; Furosemide; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Myelin Sheath; Nerve Degeneration; Neurons; Spiral Ganglion | 2013 |
Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
Topics: Animals; Anti-Bacterial Agents; Basic Helix-Loop-Helix Transcription Factors; Cochlear Diseases; Diuretics; Furosemide; Genetic Therapy; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Mice; Mice, Inbred C57BL; Regeneration | 2013 |
Deafness induction in mice.
Topics: Animals; Disease Models, Animal; Diuretics; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Mice; Spiral Ganglion | 2013 |
A guinea pig model of selective severe high-frequency hearing loss.
Topics: Action Potentials; Animals; Cochlea; Disease Models, Animal; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Loss, High-Frequency; Kanamycin | 2013 |
[Math1 gene therapy for kanamycin and furosemide-induced deaf guinea pigs].
Topics: Adenoviridae; Animals; Basic Helix-Loop-Helix Transcription Factors; Cochlea; Deafness; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Furosemide; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Kanamycin; Perilymph | 2013 |
Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
Topics: Animals; Cochlea; Cochlear Diseases; Disease Models, Animal; Female; Furosemide; Hair Cells, Auditory; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Injections, Subcutaneous; Kanamycin; Mice; Mice, Inbred CBA; Microscopy, Confocal; Organ of Corti; Radiography; Random Allocation; Reference Values; Sensitivity and Specificity; Ultrasonography | 2014 |
Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection.
Topics: Animals; Cell Survival; Dexamethasone; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Kanamycin; Male; Mice, Inbred CBA; Premedication; Time Factors; Translational Research, Biomedical | 2014 |
Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Cochlear Diseases; CX3C Chemokine Receptor 1; Disease Models, Animal; Drug Synergism; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Heterozygote; Inflammation; Kanamycin; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Receptors, Chemokine | 2014 |
Local delivery of brain-derived neurotrophic factor on the perforated round window membrane in Guinea pigs: a possible clinical application.
Topics: Animals; Brain-Derived Neurotrophic Factor; Deafness; Disease Models, Animal; Drug Administration Routes; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Guinea Pigs; Kanamycin; Round Window, Ear | 2015 |
Recovery characteristics of the electrically stimulated auditory nerve in deafened guinea pigs: relation to neuronal status.
Topics: Animals; Auditory Perception; Cochlear Implantation; Cochlear Nerve; Disease Models, Animal; Electric Stimulation; Evoked Potentials, Auditory; Female; Furosemide; Guinea Pigs; Hearing; Hearing Loss, Sensorineural; Kanamycin; Nerve Degeneration; Perceptual Masking; Reaction Time; Recovery of Function; Refractory Period, Electrophysiological; Spiral Ganglion; Time Factors | 2015 |
[The spiral ganglion degeneration and the expression of EFR3A in the cochlea of the deaf mice induced by co-administration of kanamycin and furosemide].
Topics: Animals; Cochlea; Furosemide; Hair Cells, Auditory; Kanamycin; Membrane Proteins; Mice; Mice, Inbred C57BL; Saccharomyces cerevisiae Proteins; Spiral Ganglion | 2014 |
Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
Topics: Adenoviridae; Animals; Axons; Cell Death; Disease Models, Animal; Furosemide; Gene Transfer Techniques; Genetic Therapy; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Neurons; Organ of Corti; Rats, Sprague-Dawley; Regeneration; Spiral Ganglion; Transgenes | 2015 |
Scar formation in mice deafened with kanamycin and furosemide.
Topics: Animals; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Organ of Corti | 2016 |
Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.
Topics: Acoustic Stimulation; Animals; Cell Survival; CX3C Chemokine Receptor 1; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Green Fluorescent Proteins; Hair Cells, Auditory; Hearing Loss, Noise-Induced; Interleukin-1beta; Intermediate Filaments; Kanamycin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Synthesis Inhibitors; Signal Transduction; Spiral Ganglion | 2018 |
The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Auditory Fatigue; Brain Stem; Cochlea; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gene Expression Regulation; Hearing; Hearing Loss; Inflammation Mediators; Kanamycin; Male; Oxidative Stress; Rats, Wistar; Reaction Time; Resveratrol | 2018 |
Upregulation of HSP60 expression in the postnatal rat cochlea and rats with drug-induced hearing loss.
Topics: Animals; Auditory Threshold; Chaperonin 60; Cochlea; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory; Hearing Loss; Kanamycin; Labyrinth Supporting Cells; Mitochondrial Proteins; Rats; Rats, Sprague-Dawley; Spiral Ganglion; Transcriptional Activation; Up-Regulation | 2018 |
Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model.
Topics: Animals; Azacitidine; Cochlea; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Ear, Inner; Enzyme Inhibitors; Furosemide; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Kanamycin; Mice; Regeneration | 2019 |
miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats.
Topics: Animals; Anti-Bacterial Agents; Deafness; Drug Combinations; Female; Furosemide; Kanamycin; MicroRNAs; Ototoxicity; Rats; Rats, Sprague-Dawley; Sodium Potassium Chloride Symporter Inhibitors | 2020 |
Simultaneous rather than retrograde spiral ganglion cell degeneration following ototoxically induced hair cell loss in the guinea pig cochlea.
Topics: Animals; Auditory Threshold; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Nerve Degeneration; Ototoxicity; Spiral Ganglion | 2020 |
Generation of Cochlear Hair Cells from Sox2 Positive Supporting Cells via DNA Demethylation.
Topics: Animals; Azacitidine; DNA Methylation; Female; Furosemide; Hair Cells, Auditory; Hearing Loss; Kanamycin; Male; Mice; Mice, Transgenic; SOXB1 Transcription Factors | 2020 |
Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons.
Topics: Animals; Dementia; Female; Furosemide; Hearing Loss, Sensorineural; Hippocampus; Inflammation Mediators; Kanamycin; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurons; tau Proteins | 2021 |
The ototoxic effect of locally applied kanamycin and furosemide in guinea pigs.
Topics: Animals; Cochlea; Deafness; Furosemide; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Spiral Ganglion | 2022 |
Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins.
Topics: Animals; Disease Models, Animal; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Loss, Sensorineural; Humans; Kanamycin; Spiral Ganglion | 2023 |
Agrobacterium tumefaciens-mediated genetic transformation of Salix matsudana Koidz. using mature seeds.
Topics: Agrobacterium tumefaciens; Drug Resistance; Genes, Plant; Genetic Vectors; Germination; Kanamycin; Plant Development; Plant Roots; Plant Shoots; Plants, Genetically Modified; Salix; Seeds; Transformation, Genetic | 2013 |